Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced its ...

BTIG analyst Justin Zelin downgraded Kura Oncology stock (NASDAQ:KURA) from Buy to Neutral. Zelin cited concerns over the recent KOMET-001 study results for the company's drug, ziftomenib. The ...

BTIG lowered the firm’s price target on Blue Bird (BLBD) to $45 from $55 and keeps a Buy rating on the shares. The company’s higher than ...

BTIG analyst Gregory Lewis (JO:LEWJ) revised the price target for Blue Bird Corp (NASDAQ:BLBD) shares to $45.00, down from the previous target of $55.00, while reaffirming a Buy rating on the stock.

BTIG analyst Gregory Lewis maintained a Buy rating on Blue Bird (BLBD – Research Report) today and set a price target of $45.00. The company’s ...

Am Donnerstag revidierte BTIG-Analyst Gregory Lewis das Kursziel für die Aktien von Blue Bird Corp (NASDAQ: BLBD) auf 45,00 US-Dollar, herab von zuvor 55,00 US-Dollar, bestätigte jedoch die Kaufempfeh ...

BTIG Research lowered shares of IQVIA (NYSE:IQV – Free Report) from a buy rating to a neutral rating in a research report report published on Monday morning, Marketbeat.com reports. Several other ...

StockNews.com upgraded shares of Boot Barn (NYSE:BOOT – Free Report) from a sell rating to a hold rating in a research report ...

Full-year FY 2025 revenue guidance was raised to $463M-$475M, up from $462M-$472M, while adjusted EBITDA guidance increased to $28.5M-$31M from $28M-$30M. Management anticipates stronger revenue ...

Performant Healthcare, Inc. (Nasdaq: PHLT) ("Performant"), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that it will ...